GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth

$537,942
Theresa A Guise · Indiana University Indianapolis · U01 · FY2015 · CA

Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy

$537,921
Zihai Li · Ohio State University · R01 · FY2023 · CA

Chemotherapy and the Bladder Cancer Immune Microenvironment

$537,831
William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

Targeting Senescence for Biomarkers and Therapeutics

$537,825
Anil Bhushan · University Of California, San Francisco · R01 · FY2020 · DK

Targeting Senescence for Biomarkers and Therapeutics

$537,825
Anil Bhushan · University Of California, San Francisco · R01 · FY2021 · DK

A 4D-tunable hydrogel for the study of the impact of the tumor microenvironment on the development of colorectal cancer

$537,714
Nancy L Allbritton · University Of Washington · R01 · FY2025 · CA

NextGen - CHOP

$537,702
John M Maris · Children'S Hosp Of Philadelphia · OT2 · FY2023 · CA

Determine the Role of Histone Methyltransferase ASH1L in Metastatic Prostate Cancer

$537,699
Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

Determine the Role of Histone Methyltransferase ASH1L in Metastatic Prostate Cancer

$537,699
Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence

$537,673
Veronika Fedirko · Emory University · R01 · FY2020 · CA

Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy

$537,668
Allon Moshe Klein · Harvard Medical School · R01 · FY2021 · CA

Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer

$537,633
Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer

$537,633
Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway Inhibitors

$537,585
Ankur Singh · Georgia Institute Of Technology · R01 · FY2023 · CA

TARGETING MYCOBIOME METABOLISM TO REPROGRAM THE IMMUNOSUPPRESSIVE PANCREATIC TUMOR MICROENVIRONMENT

$537,536
Regents Of The University Of Michigan · · FY2025 · Defense Health Agency

Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies

$537,395
Yoshihiro Izumiya · University Of California At Davis · R01 · FY2019 · CA

Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies

$537,395
Yoshihiro Izumiya · University Of California At Davis · R01 · FY2021 · CA

Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies

$537,395
Yoshihiro Izumiya · University Of California At Davis · R01 · FY2022 · CA

Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment

$537,303
Sylvia Katina Plevritis · Stanford University · U01 · FY2013 · CA

Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis

$537,271
Henry Shelton Earp · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA

Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis

$537,271
Henry Shelton Earp · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA

A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments

$537,134
David Kevin Wood · University Of Minnesota · R01 · FY2024 · CA

Defining the roles of mutant p53 and Mdm2 in metastasis

$537,052
Carol Prives · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA

Impact of the aging niche on cancer phenotypes probed using mouse cancer models produced by somatic engineering.

$537,050
Scott W Lowe · Sloan-Kettering Inst Can Research · U01 · FY2021 · AG

Proton-coupled folate/antifolate transport

$537,037
Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2010 · CA